ENTRY       D00323                      Drug
NAME        Flucytosine (JP18/USP/INN);
            Ancobon (TN)
  ABBR      5FC
PRODUCT     ANCOBON (Bausch Health US LLC)
  GENERIC   FLUCYTOSINE (American Health Packaging)
            FLUCYTOSINE (Aurobindo Pharma Limited)
            FLUCYTOSINE (AvPAK)
            FLUCYTOSINE (Bryant Ranch Prepack)
            FLUCYTOSINE (Bryant Ranch Prepack)
            FLUCYTOSINE (Bryant Ranch Prepack)
            FLUCYTOSINE (Bryant Ranch Prepack)
            FLUCYTOSINE (Bryant Ranch Prepack)
            FLUCYTOSINE (Bryant Ranch Prepack)
            FLUCYTOSINE (Cameron Pharmaceuticals)
            FLUCYTOSINE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            FLUCYTOSINE (Lupin Pharmaceuticals)
            FLUCYTOSINE (Major Pharmaceuticals)
            FLUCYTOSINE (Novel Laboratories)
            FLUCYTOSINE (Sigmapharm Laboratories)
            FLUCYTOSINE (West-Ward Pharmaceuticals Corp)
FORMULA     C4H4FN3O
EXACT_MASS  129.0338
MOL_WEIGHT  129.0925
REMARK      Therapeutic category: 6290
            ATC code: D01AE21 J02AX01
            Product: D00323<JP/US>
EFFICACY    Antifungal, Nucleic acid biosynthesis inhibitor
  DISEASE   Candidiasis [DS:H00363]
            Cryptococcosis [DS:H00364]
COMMENT     Fluoropymidine derivative
            Flucytosine is converted into Fluorouracil [DR:D00584] by susceptible fungal cells.
TARGET      TYMS [KO:K00560]
  PATHWAY   ko00240(K00560)  Pyrimidine metabolism
INTERACTION  
STR_MAP     map07026  Antifungal agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
               D01A ANTIFUNGALS FOR TOPICAL USE
                D01AE Other antifungals for topical use
                 D01AE21 Flucytosine
                  D00323  Flucytosine (JP18/USP/INN) &lt;JP/US&gt;
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J02 ANTIMYCOTICS FOR SYSTEMIC USE
               J02A ANTIMYCOTICS FOR SYSTEMIC USE
                J02AX Other antimycotics for systemic use
                 J02AX01 Flucytosine
                  D00323  Flucytosine (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antifungals
              Flucytosine
               D00323  Flucytosine (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               629  Miscellaneous
                6290  Miscellaneous
                 D00323  Flucytosine (JP18/USP/INN)
            Antimicrobials [BR:br08307]
             Antifungals
              Nucleic acid synthesis inhibitor
               Fluoropyrimidine
                D00323  Flucytosine (JP18/USP/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antifungals
              Nucleic acid synthesis inhibitor
               Fluoropyrimidine
                D00323  Flucytosine (JP17/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00323  Flucytosine
DBLINKS     CAS: 2022-85-7
            PubChem: 7847389
            ChEBI: 5100
            PDB-CCD: 1LD
            LigandBox: D00323
            NIKKAJI: J3.695A
ATOM        9
            1   C8y C    22.2270  -17.0929
            2   C8y C    23.4436  -16.4001
            3   N5x N    22.2270  -18.4957
            4   N1a N    21.0104  -16.3943
            5   C8x C    24.6486  -17.0929
            6   X   F    23.4436  -14.9972
            7   C8y C    23.4436  -19.1943
            8   N4x N    24.6486  -18.4957
            9   O5x O    23.4436  -20.5971
BOND        9
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     5   8 1
            8     7   9 2
            9     7   8 1
///
